Rani Therapeutics to Participate in September Conferences
Rani Therapeutics, a clinical-stage biotherapeutics company focused on oral biologics, announced management will attend the upcoming September BIG10 and H.C. Wainwright conferences.
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
SAN JOSE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s management team will participate in the upcoming September conferences.
10th Annual Best Ideas Growth (BIG10) Conference hosted by Lake Street Capital Markets
Date: Thursday, September 10, 2026
Format: 1×1 Meetings
Location: New York, NY
H.C. Wainwright 28th Annual Global Investment Conference
Fireside Chat: Monday, September 14, 2026 at 4:00pm E.T.
Presenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, Nicholas Maestas
Format: Fireside Chat and 1×1 Meetings
Location: New York, NY
Interested parties can access the live webcast for the H.C. Wainwright conference from the Investor Relations section of the company’s website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the presentation.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® Capsule™, a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® Capsule technology.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
